Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (SABS).
- Disclosed ownership: 9.1%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 9.1% ownership in SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (SABS) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 5.1% | 2,540,159 | 0 | 2,540,159 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 5.1% | 2,540,159 | 0 | 2,540,159 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 3.9% | 1,931,905 | 0 | 1,931,905 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 3.9% | 1,931,905 | 0 | 1,931,905 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.5% | 225,556 | 0 | 225,556 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.5% | 225,556 | 0 | 225,556 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 8.6% | 4,472,064 | 0 | 4,472,064 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 9.1% | 4,761,906 | 0 | 4,761,906 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 9.1% | 4,761,906 | 0 | 4,761,906 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 9.1% | 4,761,906 | 0 | 4,761,906 | /s/ Mark N. Lampert | Mark N. Lampert |